What is the risk of acute hepatic failure after ingesting 16 g of paracetamol (acetaminophen) in the first 24 hours followed by 12 g in the next 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Risk of Hepatic Failure After 16g + 12g Paracetamol Ingestion

This ingestion pattern (28g total over 48 hours) represents a repeated supratherapeutic overdose with substantial risk of severe hepatotoxicity and potential acute liver failure, particularly if treatment is delayed beyond 10 hours from the first ingestion.

Quantifying the Risk

The total dose of 28g substantially exceeds toxic thresholds. Based on guideline evidence, this scenario carries significant hepatotoxicity risk:

  • For repeated supratherapeutic ingestions: The pattern described (16g in first 24h, 12g in next 24h) far exceeds the referral threshold of ≥10g in a single 24-hour period 1
  • Severe hepatotoxicity rates in untreated or delayed-treatment cases historically approach 58% 1
  • Mortality risk in delayed treatment (>10 hours) ranges from 5-27% depending on treatment timing 1

Critical Time-Dependent Factors

The risk of progression to hepatic failure is heavily time-dependent:

If NAC Started Early (<8-10 hours):

  • Severe hepatotoxicity risk: 2.9-6.1% 1
  • Mortality: essentially 0% 1
  • This represents the critical therapeutic window

If NAC Started 10-16 hours:

  • Severe hepatotoxicity risk: 29% 1
  • Mortality increases significantly

If NAC Started 16-24 hours:

  • Severe hepatotoxicity risk: 62% 1
  • Mortality: up to 5% even with treatment 1

If NAC Started >24 hours:

  • Risk substantially elevated, though NAC still provides benefit 1

Management Algorithm

Immediate actions regardless of presentation time:

  1. Administer NAC immediately - do not wait for laboratory results in this dose range 1

    • The Rumack-Matthew nomogram does NOT apply to repeated supratherapeutic ingestions 1
    • Treatment should be empiric based on reported dose alone
  2. Obtain baseline laboratories:

    • Serum paracetamol level (though not for nomogram use in this case)
    • AST/ALT (hepatotoxicity defined as AST >1,000 IU/L) 1
    • INR/PT (coagulopathy assessment)
    • Monitor every 12-24 hours 2
  3. Continue NAC until:

    • Paracetamol level undetectable
    • Transaminases stable or declining
    • INR normal
    • Minimum 72 hours monitoring before discontinuation 3

Special Considerations for This Pattern

Repeated supratherapeutic ingestions have worse prognosis than single acute overdoses 1. Key concerns:

  • Cannot risk-stratify using standard nomogram 1
  • May have delayed peak paracetamol levels (up to 54 hours reported) 3
  • Approximately 30% of acetaminophen overdose admissions involve this pattern 1
  • 42-51% of acute liver failure cases in the US are acetaminophen-related 4

Pitfalls to Avoid

  1. Do not rely on normal transaminases in ED - hepatotoxicity may develop over subsequent hours 1
  2. Do not stop NAC prematurely - monitor for at least 72 hours after large overdoses 3
  3. Do not attempt nomogram-based risk stratification - this is a repeated ingestion pattern 1
  4. Consider psychiatric evaluation - 48% of cases are unintentional, often involving chronic pain and multiple preparations 4

Prognosis With Appropriate Treatment

With immediate NAC administration, transplant-free survival is approximately 65-71% 4. However, delayed presentation (>15 hours) is associated with liver damage in most untreated cases 5. The median ingested dose in acetaminophen-induced acute liver failure is 24g 4, making this 28g ingestion particularly concerning.

Level B recommendation: Administer NAC to patients with hepatic failure thought to be due to acetaminophen 1. Level C recommendation: Administer NAC to patients who have hepatotoxicity and suspected acetaminophen overdose, including repeated supratherapeutic ingestions 1.

References

Research

[Acute acetaminophen overdose].

La Revue du praticien, 2008

Research

Delayed and prolonged elevated serum paracetamol level after an overdose - possible causes and implications.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2011

Research

[Paracetamol poisoning--occurrence and treatment].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006

Related Questions

In a patient who ingested 8,500 mg acetaminophen over 20 hours, weighs 85 kg, and has normal liver function tests, should N‑acetylcysteine be started in the emergency department?
In a 27-year-old woman who ingested 24 acetaminophen tablets (~12 g) after two prior suicide attempts, which of the following statements is incorrect: A) Risk of hepatic and renal injury; B) Immediate administration of N‑acetylcysteine; C) Measuring acetaminophen levels and delaying N‑acetylcysteine; D) Assessment of hepatic and renal function; E) Concomitant alcohol use increases toxicity?
In a 28-year-old male with no comorbidities who ingested a single dose of three 650 mg tablets of paracetamol after intermittent alcohol consumption over the preceding three days, how should he be managed?
In a 20-year-old female who ingested 9.8 g of paracetamol within 2 hours, what is the appropriate management?
In urgent care, can I manage a ~20‑year‑old woman who accidentally ingested five Excedrin (acetaminophen/aspirin/caffeine) tablets a few hours ago and has a history of autoimmune hepatitis?
In an 86‑year‑old female nursing‑home resident with dementia, depression, anxiety, and insomnia who is currently taking melatonin 5 mg nightly, mirtazapine 15 mg nightly, venlafaxine 112.5 mg daily, and valproic acid 125 mg twice daily and now presents with severe anxiety, paranoia, agitation, hypervigilance, restlessness, wandering, and frequent emotional outbursts, what is the best plan for psychotropic medication management?
Is there an increased risk of bleeding in patients with a history of immune thrombocytopenia (ITP) who have recovered and have normal platelet counts?
I am a 30‑year‑old male with a likely pathogenic TTN I‑band variant and a normal recent transthoracic echocardiogram; after increasing alcohol intake and experiencing exertional chest pain with normal BNP, troponin, and ECG, should I limit or avoid alcohol to prevent cardiomyopathy?
For a patient with sutures that are still bleeding, can I apply Surgicell (oxidized regenerated cellulose) over the sutures, or should I order local endoscopic/laser therapy (L.E.T)?
What are the primary strategies to prevent sudden infant death syndrome (SIDS) in infants under one year of age?
Can a 24‑hour‑old laceration be sutured?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.